InvestorsHub Logo
Followers 55
Posts 6415
Boards Moderated 1
Alias Born 07/28/2015

Re: foti1kenobi post# 67575

Monday, 09/14/2020 11:32:32 AM

Monday, September 14, 2020 11:32:32 AM

Post# of 113741
It won't pass unless it is amended, much like their 10Q/a.

They didn't have to pay a dime to submit a covid-19 patent and then publicized they filed a priority patent.

Anyone can file a patent for free if it is labeled a New Drug Application for covid-19. But it has to pass as a covid-19 New Drug Application, which is NOT THE SAME AS A NDA (Non Disclosure Agreement)

In order to do so, you must also file an FDA application as well.

Now it is in "patent pending" status with "more information required" before it can be processed.

If this does not happen, it will be rejected or denied.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News